GlassScriptPhysician profile
Lawrence M Bruksch
NPI 1073562203
$1,901.00
in general payments reported to CMS, 2019-2025
21 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $863 · 2020: $79.03 · 2021: $169 · 2022: $193 · 2023: $406 · 2024: $42.19 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $641.62 | 2019 | |
| Abbvie INC. | $410.13 | 2020-2023 | Lo Loestrin Fe, Liletta, Orilissa |
| Becton, Dickinson and Company | $136.66 | 2019 | |
| Coopersurgical, INC. | $89.60 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Therapeuticsmd, INC. | $89.40 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $81.95 | 2023-2024 | |
| Sage Therapeutics, LLC | $80.23 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $63.72 | 2023-2025 | Aptima, Novasure, Fluent Fluid Management System |
| Aspira Women'S Health INC | $37.08 | 2021-2023 | Ova1 |
| Avion Pharmaceuticals | $35.53 | 2022-2023 | Balcoltra |
| Minerva Surgical, INC | $34.31 | 2023 | |
| Millicent US INC | $23.25 | 2025 | Intrarosa, Femlyv |
| Baxter Healthcare | $22.86 | 2023 | Seprafilm |
| Shield Therapeutics INC | $22.61 | 2023 | Accrufer |
| Organon LLC | $22.20 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $21.46 | 2022 | |
| Astellas Pharma US INC | $21.27 | 2024 | Veozah |
| Evofem Biosciences, INC. | $20.17 | 2022 | |
| Convatec INC. | $18.19 | 2019 | |
| Mylan Pharmaceuticals INC. | $16.46 | 2021 | |
| Ascend Therapeutics US, LLC | $12.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Bruksch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.